Literature DB >> 9028950

Specific accumulation of circulating monocytes and polymorphonuclear leukocytes on platelet thrombi in a vascular injury model.

D Kirchhofer1, M A Riederer, H R Baumgartner.   

Abstract

The adhesion of leukocytes to platelets deposited at the site of vascular injury may represent an important mechanism by which leukocytes contribute to hemostasis and thrombosis. In this study, we examined whether, in comparison with their distribution in circulating blood, certain leukocyte types are enriched at sites of platelet deposition. We used an experimental vascular injury model, in which human fibrillar collagen was exposed to anticoagulated human whole blood flowing through parallel-plate chambers (venous shear rate, 65/s). The platelet-adherent leukocytes were detached by EDTA treatment and analyzed by flow cytometry using cell-type-specific antibodies. The predominant leukocytes found in platelet thrombi were polymorphonuclear leukocytes, accounting for 76% of bound leukocytes (62% in circulating blood), whereas T and B lymphocytes did not significantly accumulate on thrombi, comprising a fraction of less than 5% (32% in circulating blood). Monocytes constituted 16% of platelet thrombus-bound leukocytes, which represents an almost fourfold enrichment as compared with their proportion in circulating blood. Almost identical results were obtained when we analyzed leukocytes adhering to platelet monolayers, which were formed by blocking glycoprotein IIb-IIIa, thus preventing platelet aggregation on top of the collagen-adherent platelets. Furthermore, leukocyte adhesion to platelet monolayers was completely inhibited by an anti-P-selectin antibody (50% inhibitory concentration, 0.3 microg/mL), whereas it reached a plateau at about 70% inhibition on platelet thrombi. This difference could be explained by a possible function of glycoprotein IIb-IIIa in leukocyte immobilization to thrombi or by the high local concentration of P-selectin in the growing thrombi. The results suggest that, because of their known abilities to promote coagulation and thrombolysis, the monocytes and polymorphonuclear leukocytes accumulating on forming platelet thrombi could play an important role in modulating thrombotic and hemostatic processes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9028950

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  P-Selectin: Basic Aspects.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-09       Impact factor: 2.300

Review 2.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

Review 3.  The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a review.

Authors:  Devendra Kc; Lorenzo Falchi; Srdan Verstovsek
Journal:  Ann Hematol       Date:  2017-08-14       Impact factor: 3.673

4.  Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis.

Authors:  Q Xiao; M J Danton; D P Witte; M C Kowala; M T Valentine; T H Bugge; J L Degen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

5.  Effect of intravenous lidocaine on the transcerebral inflammatory response during cardiac surgery: a randomized-controlled trial.

Authors:  Rebecca Y Klinger; Mary Cooter; Miles Berger; Mihai V Podgoreanu; Mark Stafford-Smith; Thomas L Ortel; Ian J Welsby; Jerrold H Levy; Henry M Rinder; Mark F Newman; Joseph P Mathew
Journal:  Can J Anaesth       Date:  2016-07-28       Impact factor: 5.063

6.  Blood-borne tissue factor: another view of thrombosis.

Authors:  P L Giesen; U Rauch; B Bohrmann; D Kling; M Roqué; J T Fallon; J J Badimon; J Himber; M A Riederer; Y Nemerson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

7.  Leukocyte count is associated with increased platelet reactivity and diminished response to aspirin in healthy individuals with a family history of coronary artery disease.

Authors:  Nauder Faraday; Lisa R Yanek; Dhananjay Vaidya; Brian Kral; Rehan Qayyum; J Enrique Herrera-Galeano; Taryn F Moy; Diane M Becker; Lewis C Becker
Journal:  Thromb Res       Date:  2009-01-30       Impact factor: 3.944

8.  Neutrophil granulocyte-dependent proteolysis enhances platelet adhesion to the arterial wall under high-shear flow.

Authors:  N Wohner; Z Keresztes; P Sótonyi; L Szabó; E Komorowicz; R Machovich; K Kolev
Journal:  J Thromb Haemost       Date:  2010-04-20       Impact factor: 5.824

9.  Contribution of neutrophil elastase to the lysis of obliterative thrombi in the context of their platelet and fibrin content.

Authors:  Gyöngyi Rábai; Nóra Szilágyi; Péter Sótonyi; Ilona Kovalszky; László Szabó; Raymund Machovich; Krasimir Kolev
Journal:  Thromb Res       Date:  2010-08       Impact factor: 3.944

10.  Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation.

Authors:  Christian Pfluecke; Daniel Tarnowski; Lina Plichta; Katharina Berndt; Paul Schumacher; Stefan Ulbrich; Mathias Forkmann; Marian Christoph; David M Poitz; Carsten Wunderlich; Ruth H Strasser; Karim Ibrahim
Journal:  Clin Res Cardiol       Date:  2015-09-28       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.